Nebicard LN 5 Mg (Nebivolol/Cilnidipine)

Price range: $32.00 through $77.00

Buy Nebicard LN 5 mg (nebivolol + cilnidipine) online. Combination therapy for essential hypertension. Prescription required. Ships globally.

  Hurry up! Sale end in:
  ... people are viewing this right now

  Share
Guaranteed Safe Checkout

Available Options

Pack SizePriceQuantity 
30 Tablet/s$32.00
60 Tablet/s$55.00
90 Tablet/s$77.00

Buy Nebicard LN 5 mg (Nebivolol + Cilnidipine) – Dual‑Action Therapy for Hypertension

Nebicard LN 5 mg tablets combine nebivolol (5 mg, β₁‑selective blocker with nitric oxide potentiation) and cilnidipine (10 mg, L- & N‑type calcium-channel blocker) to control essential hypertension in adults when monotherapy is insufficient. 

How It Works

Nebivolol slows heart rate and stimulates endothelial nitric oxide release to dilate vessels; cilnidipine relaxes vascular smooth muscle—together reducing both cardiac output and peripheral resistance. 

Uses & Benefits

  • Treats essential hypertension when single-agent therapy is inadequate. 
  • Dual mechanism improves blood pressure control and reduces cardiovascular risk. 

Dosage & Administration

  • Take one tablet once daily—swallow whole with water; do not crush or chew. May be taken with or without food.
  • Begin with Nebicard LN 5 mg; dosage adjustments depend on clinical response. 
  • If a dose is missed, take it as soon as remembered unless it’s close to the next dose—do not double up. 

Common Side Effects & Safety

  • Common: headache, dizziness, fatigue, flushing, peripheral edema, nausea, slow heart rate, constipation, cold hands/feet, frequent urination. 
  • Less common: palpitations, breathlessness, paresthesia or gastro symptoms. 

⚠️ Precautions & Interactions

  • Avoid alcohol—it may amplify blood-pressure-lowering effects and dizziness. Do not drive or operate machinery until tolerance is assessed. 
  • Contraindications: severe bradycardia, heart block above first degree, cardiogenic shock, liver disease, asthma/COPD, hypotension. 
  • Drug interactions include antifungals, antidepressants (fluoxetine), digoxin, calcium-channel blockers, NSAIDs—monitor for hypotension or bradycardia. 
  • Caution advised in elderly (>75 years), diabetes (masked hypoglycemia), kidney disease. 

Global Availability & Prescription Info

Nebicard LN 5 mg is prescription-only, manufactured by Torrent Pharmaceuticals in India, and available globally through licensed pharmacies. Treatment requires physician oversight and periodic monitoring. 

📌 Frequently Asked Questions (FAQs)

1. What is Nebicard LN 5 mg used for?

It is used to manage high blood pressure when monotherapy is inadequate, combining nebivolol and cilnidipine for a dual antihypertensive effect. 

2. When will I notice improvements?

Blood pressure reduction may begin within hours; steady control usually achieved within days with once-daily dosing. 

3. What side effects can occur?

Common effects: headache, dizziness, flushing, fatigue, swelling feet, slow heartbeat, constipation or nausea. Most resolve over time. 

4. Can I suddenly stop it?

No—abrupt cessation may cause rebound hypertension or heart rate changes. Always taper under medical advice. 

5. Are there food or drug interactions?

Avoid combining with verapamil or diltiazem, avoid alcohol, inform your doctor if taking digoxin, antidepressants, antifungals, or NSAIDs. Monitor diabetic and elderly patients carefully. 

0.00
0 reviews
5
0
4
0
3
0
2
0
1
0
Be the first to review “Nebicard LN 5 Mg (Nebivolol/Cilnidipine)”

Your email address will not be published. Required fields are marked *

This field is required.

This field is required.

This field is required.

Reviews

There are no reviews yet.

My Cart
Recently Viewed
Categories
Compare Products (0 Products)
Nebicard LN 5 Mg (Nebivolol/Cilnidipine)

Nebicard LN 5 Mg (Nebivolol/Cilnidipine)

Price range: $32.00 through $77.00

Request a Call Back

    Nebicard LN 5 Mg (Nebivolol/Cilnidipine)

    Nebicard LN 5 Mg (Nebivolol/Cilnidipine)

    Price range: $32.00 through $77.00

    Ask a Question